Novo Nordisk enters collaboration with University of Oxford on type 2 diabetes.

Novo Nordisk enters collaboration with University of Oxford on type 2 diabetes.


Our Chief Science Officer Mads Krogsgaard Thomsen shares his perspective on the collaboration with University of Oxford on Type 2 diabetes.


source


Comments

Popular posts from this blog

Alcohol, Aging, and Curing Cancer